Literature DB >> 11520600

Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells.

T Tamatani1, M Azuma, K Aota, T Yamashita, T Bando, M Sato.   

Abstract

The nuclear transcription factor kappaB (NF-kappaB) plays an important role in the development and progression of cancers. However, the mechanism by which cancer cells in the head and neck region acquire high NF-kappaB activity has not yet been clarified. In this study, we examined the NF-kappaB binding activity and the expression of the signal-transduction-related proteins of NF-kappaB in head and neck carcinoma cell lines. These cancer cells showed significantly higher NF-kappaB binding activity than normal oral epithelial and salivary gland cells. We also demonstrated the increased phosphorylation and degradation of IkappaB-alpha protein in cancer cells. Thus, enhanced NF-kappaB activity in cancer cells is attributable to the rapid phosphorylation and degradation of IkappaB-alpha protein. To further elucidate the mechanism involved in this phenomenon, we analyzed both the expression levels of upstream kinases (IkappaB kinase- (IKK-) alpha, IKK-beta, IKK-gamma, and NF-kappaB-inducing kinase (NIK)) and the IKK activity in cells. Although there was no significant difference in the expression levels of NIK, IKK-beta, or IKK-gamma in cancer cell lines compared to those in normal cells, increased expression of IKK-alpha protein was observed in cancer cells. In addition, IKK activity was significantly augmented in cancer cells as compared to normal cells. Thus, our results suggest that enhanced NF-kappaB activity in head and neck cancer cells may be due to the augmentation of IKK activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520600     DOI: 10.1016/s0304-3835(01)00611-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.

Authors:  Ming Yu; Jason Yeh; Carter Van Waes
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

2.  Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.

Authors:  Mitchell J Frederick; Amy J VanMeter; Mayur A Gadhikar; Ying C Henderson; Hui Yao; Curtis C Pickering; Michelle D Williams; Adel K El-Naggar; Vlad Sandulache; Emily Tarco; Jeffrey N Myers; Gary L Clayman; Lance A Liotta; Emanuel F Petricoin; Valerie S Calvert; Valentina Fodale; Jing Wang; Randal S Weber
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  High-affinity interaction between IKKbeta and NEMO.

Authors:  Yu-Chih Lo; Upendra Maddineni; Jee Y Chung; Rebecca L Rich; David G Myszka; Hao Wu
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

Review 4.  Structural studies of NF-κB signaling.

Authors:  Chao Zheng; Qian Yin; Hao Wu
Journal:  Cell Res       Date:  2010-12-07       Impact factor: 25.617

Review 5.  Role of nuclear factor-kappa B in melanoma.

Authors:  Katayoun I Amiri; Ann Richmond
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

Review 6.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

7.  Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.

Authors:  R Chen; A B Alvero; D A Silasi; M G Kelly; S Fest; I Visintin; A Leiser; P E Schwartz; T Rutherford; G Mor
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

Review 8.  NF-kappaB and cancer: how intimate is this relationship.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bharat B Aggarwal
Journal:  Mol Cell Biochem       Date:  2009-10-08       Impact factor: 3.396

9.  Glottic versus supraglottic tumors: differential molecular profile.

Authors:  Konstantinos Kourelis; Theodoros Papadas; Gerasimos Vandoros; Panos Goumas; Georgia Sotiropoulou-Bonikou
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-02       Impact factor: 2.503

10.  Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system.

Authors:  Susan E Wurster; John Paul Bida; Yeng F Her; L James Maher
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.